Clinical trial
Optimization of Treatment for Patients With Chronic Hepatitis C Infected With HCV-genotype 2 or 3: 12 vs. 24 Weeks of Treatment Extension for Patients Without Rapid Virological Response
NCT00803309 is registered in ClinicalTrials.gov with HepNet Study House, German Liverfoundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimization of Treatment for Patients With Chronic Hepatitis C Infected With HCV-genotype 2 or 3: 12 vs. 24 Weeks of Treatment Extension for Patients Without Rapid Virological Response
- Lead sponsor
- HepNet Study House, German Liverfoundation
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- November 30, 2008
- Completion date
- August 31, 2013
- Enrollment
- 99 (actual)
- Sites
- 49
Conditions
As the registry lists them; a condition with its own page is linked.